You will not be allowed to compare more than 4 products at a time
View compareScience
At the heart of Medolife SRL is a commitment to scientific innovation and rigorous research. Our flagship product, Escozine , is the result of years of exploration into the unique properties of the venom of the Rhopalurus princeps scorpion. Using cutting-edge polarization technology, we have developed a biologic medicine that improves cancer care by addressing multiple critical aspects of patient well-being. Below, we delve into the science behind Escozine and the research supporting its powerful benefits.
Improves the Results of Conventional Treatments
Escozine enhances the effectiveness of conventional cancer therapies, such as chemotherapy and radiation, by making cancer cells more susceptible to these treatments. Through the action of chloride channel inhibitors, Escozine interferes with key pathways that cancer cells use to develop resistance. By disrupting chloride channels, Escozine impairs the ability of cancer cells to maintain their internal environment, allowing chemotherapy agents to more effectively penetrate and accumulate within cells. This process may help reverse chemotherapy resistance, increasing the sensitivity of cancer cells to treatment.
Improve the Quality of Life
Escozine is designed to improve the overall quality of life of cancer patients by addressing multiple symptoms including pain, fatigue, poor sleep, and poor appetite. Escozine’s unique bioactive compounds, primarily peptides, function as ion channel inhibitors, targeting chloride, sodium, potassium, and calcium channels. These inhibitors help regulate cellular processes that reduce inflammation, promote muscle function, and stabilize neuronal activity, resulting in improved physical and mental well-being. The reduction in pain and inflammation allows patients to live more comfortably and stay active during their treatment.
Helps Control Cachexia
Cachexia, a severe form of weight and muscle loss commonly seen in patients with advanced cancer, severely impacts quality of life and survival rates. Escozine helps manage cachexia by modulating the hormone ghrelin, known as the “hunger hormone.” Ghrelin is crucial for appetite regulation, energy balance, and intestinal motility. By increasing ghrelin activity, Escozine stimulates appetite and reduces muscle loss. Additionally, the sodium and potassium channel inhibitors in Escozine work to preserve muscle function and energy balance, stabilizing patients’ weight and strength.
May Reverse Chemotherapy Resistance
One of Escozine’s most promising applications is its ability to reverse chemotherapy resistance. Cancer cells can become resistant to treatments over time, reducing the effectiveness of chemotherapy drugs. Escozine’s chloride channel inhibitors may help disrupt cancer cells’ resistance mechanisms, allowing chemotherapy drugs to penetrate cancer cells more effectively. This action may increase the susceptibility of cancer cells to conventional treatments and help restore the effectiveness of chemotherapy.
Improves Appetite, Energy and Sleep
Cancer treatments often cause disruptions in appetite, energy levels, and sleep – all essential to a patient’s recovery. Escozine addresses these issues through its multi-ion channel inhibition approach. Potassium and calcium channel inhibitors work to stabilize neuronal activity and reduce stress on the nervous system, promoting better sleep quality. Meanwhile, modulation of ghrelin and reduction of inflammatory cytokines help restore appetite and energy levels, allowing patients to regain strength and vitality.